A study published in JAMA Network Open revealed that the Childhood Asthma Risk Tool outperformed the Asthma Predictive Index, which requires invasive tests, as well as diagnoses by physicians.
An artificial intelligence-guided system that uses retinal scans to determine if an individual is likely to experience stroke or heart disease was developed by researchers in the UK. The fully automated tool, called QUARTZ, or QUantitative Analysis of Retinal vessels Topology and siZe, can produce 10-year risk scores.
Rescue Biomedical has received a $2.8 million Fast-Track Small Business Innovation Research grant from the National Institutes of Health to further the development of its implant to aid patients with opioid use disorder. The subcutaneous, minimally invasive device delivers naloxone when it detects opioid overdose in the user.
A study conducted by Seoul National University Bundang Hospital researchers found the Spine MT spinal decompression treatment tool was an effective option for patients with spinal disc diseases.
Final FDA guidance on regulating Clinical Decision Support (CDS) software as a medical device deviates from draft guidance issued in 2019. CDS software that is designed to acquire or analyze medical images or signals from diagnostic devices may be subject to regulation as a device; however, software designed for other purposes that meets three other criteria may be exempt.
Researchers at MIT and the University of Rochester Medical Center have developed a device to monitor a Parkinson’s patient at home.
Researchers in Fredericton say they have developed an app to help flag and reduce potentially inappropriate or unnecessary use of medications in nursing homes.
As the U.S. gatekeeper for medical tests, how should the FDA strike a balance between making sure the public has options during a national emergency and making sure those tests actually work? The Agency’s stumbles during the earliest stages of the COVID-19 pandemic hold some important lessons, according to a report from the inspector general of the Department of Health and Human Services (HHS).
Over the course of the last decade or so, smartphones have slowly morphed into full-fledged medical tools. Mobile devices are now being used to read diagnostic test results, scan photos taken by their built-in cameras to spot signs of disease and even to take the place of pulse oximeters in measuring blood oxygen levels.
Researchers from Stanford, USC, Georgia Tech, and the University of Tokyo have developed a battery-powered digital health wearable that attaches to the skin and can measure tumor size continuously and in real time, offering hope for advancements in both cancer research and treatment.